Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Who is More at Risk of Adverse Events After Coronary Procedures?
1
Mins
July 2024
New study highlights the need for targeted anti-inflammatory treatments to reduce adverse cardiovascular events in high-risk patients.
Read more
4
Mins
2nd June 2016
European Commission Approves TREVICTA®(Paliperidone Palmitate a 3-Monthly Injection), for Maintenance Treatment of Schizophrenia
BEERSE, BELGIUM, 31st May 2016 – Janssen-Cilag International NV announced today that the European Commission (EC) has approved the use of TREVICTA®…
4
Mins
27th April 2016
Celyad Receives Certification for C-Cure® Non-Clinical Data from the European Medicines Agency (EMA)
C-Cure® (C3BS-CQR-1) is a cardiovascular lineage-committed cell therapy product being developed for the treatment of ischemic heart failure
1
Mins
25th April 2016
Physical Exercise Combats Depression Post Heart Attack
UNIQUE data has shed light on the mental health of individuals who have experienced a heart attack. The analysis, which used the data collected from…
1
Mins
25th April 2016
Functional Cardiac Muscle Cells can be Successfully Regenerated
BIOENGINEERED human hearts are becoming a reality after a team of researchers successfully generated cardiomyocytes (cardiac muscle cells)…
4
Mins
21st April 2016
Heart Attack Patients More Depressed but Get Less Antidepressants
Athens, Greece – 16 April 2016: Heart attack patients are more depressed but are less often prescribed antidepressants than people who have not had a…
2
Mins
11th March 2016
Treatment Advances and New Centres of Excellence Offer Lifeline to Patients with Inoperable Neuroendocrine Cancers
1 March 2016: A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope…
1
Mins
19th February 2016
Introducing the European Medical Journal 1.1
United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
3
Mins
15th February 2016
Mecca’s Cardiac Hospital Describes How it Copes with the Hajj
Riyadh, Saudi Arabia, 12 February 2016: Mecca’s cardiac hospital has described how it copes with the huge patient influx during the Hajj and…
Loading posts...
« Previous
1
…
16
17
18
19
20
…
24
Next »